Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Mayes

Showing results (191-200 of 382) with videos related to

Pageof 39
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|November 3, 2020
Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double-Blind, Placebo-Controlled TrialToby M Maher, Maureen D Mayes, Michael Kreuter, et al.
Annals of the Rheumatic Diseases|August 24, 2019
Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosisMinghua Wu, Brian Skaug, Xiongjie Bi, et al.
Arthritis Care & Research|August 27, 2010
Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung studyKaren Au, Maureen D Mayes, Paul Maranian, et al.
Arthritis Care & Research|October 10, 2013
Biopsychosocial typologies of pain in a cohort of patients with systemic sclerosisErin L Merz, Vanessa L Malcarne, Shervin Assassi, et al.
The Journal of Rheumatology|November 17, 2018
Associations of Multiple <i>NOTCH4</i> Exonic Variants with Systemic SclerosisXiaodong Zhou, Hongye Li, Shicheng Guo, et al.
Frontiers in Pharmacology|January 22, 2026
Esomeprazole inhibits proliferation of scleroderma fibroblasts via cell cycle regulationMohammad A Khan, Shaheer Koniyan, Manisha Ahir, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|April 28, 2026
Age-Specific Clinical Biomarker Ranges in Acute Head Injury, Non-TBI Trauma, and Healthy Control Subjects in the Emergency DepartmentKatherine D Mayes, Timothy E Van Meter, Nazanin Mirshahi, et al.
Arthritis and Rheumatism|November 1, 2006
Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of sclerodermaSou-Pan Wu, Lin Leng, Zeny Feng, et al.
Annals of the Rheumatic Diseases|December 23, 2021
Large-scale analysis of longitudinal skin gene expression in systemic sclerosis reveals relationships of immune cell and fibroblast activity with skin thickness and a trend towards normalisation over timeBrian Skaug, Marka A Lyons, William R Swindell, et al.
Autoimmunity|September 4, 2015
Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjectsMichael Wodkowski, Marie Hudson, Susanna Proudman, et al.
Pageof 39

Showing results (191-200 of 382) with videos related to

Sort By:
Pageof 39
Arthritis & Rheumatology (Hoboken, N.J.)|November 3, 2020
Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double-Blind, Placebo-Controlled TrialToby M Maher, Maureen D Mayes, Michael Kreuter, et al.
Annals of the Rheumatic Diseases|August 24, 2019
Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosisMinghua Wu, Brian Skaug, Xiongjie Bi, et al.
Arthritis Care & Research|August 27, 2010
Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung studyKaren Au, Maureen D Mayes, Paul Maranian, et al.
Arthritis Care & Research|October 10, 2013
Biopsychosocial typologies of pain in a cohort of patients with systemic sclerosisErin L Merz, Vanessa L Malcarne, Shervin Assassi, et al.
The Journal of Rheumatology|November 17, 2018
Associations of Multiple <i>NOTCH4</i> Exonic Variants with Systemic SclerosisXiaodong Zhou, Hongye Li, Shicheng Guo, et al.
Frontiers in Pharmacology|January 22, 2026
Esomeprazole inhibits proliferation of scleroderma fibroblasts via cell cycle regulationMohammad A Khan, Shaheer Koniyan, Manisha Ahir, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|April 28, 2026
Age-Specific Clinical Biomarker Ranges in Acute Head Injury, Non-TBI Trauma, and Healthy Control Subjects in the Emergency DepartmentKatherine D Mayes, Timothy E Van Meter, Nazanin Mirshahi, et al.
Arthritis and Rheumatism|November 1, 2006
Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of sclerodermaSou-Pan Wu, Lin Leng, Zeny Feng, et al.
Annals of the Rheumatic Diseases|December 23, 2021
Large-scale analysis of longitudinal skin gene expression in systemic sclerosis reveals relationships of immune cell and fibroblast activity with skin thickness and a trend towards normalisation over timeBrian Skaug, Marka A Lyons, William R Swindell, et al.
Autoimmunity|September 4, 2015
Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjectsMichael Wodkowski, Marie Hudson, Susanna Proudman, et al.
Pageof 39